Find Clinical Trial

Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life in Patients with Metastatic Colorectal Cancer


← Back
Study Phase

Phase 4

Therapeutic Area

Cancers

Active substance/
Medical device

TIPIRACIL, TRIFLURIDINE

SponsorServier Deutschland GmbH
Active Substance CodeS095005
Protocol CodeIC4-95005-183-DEU
EudraCT Code2017-000292-83
ISRCTN CodeISRCTN90009147
Other Protocol Name :Tallisur
DRKS00012977


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility